How long can you take Mitotane?

Mitotane(Mitotane) is an oral drug with selective adrenocortical cytotoxicity, mainly used to treat advanced or unresectable adrenocortical carcinoma (ACC; adrenal carcinoma). Its treatment cycle and dose management are highly individualized, so patients usually need long-term use under the guidance of a doctor. The initial dose of mitotane is usually between 2 grams and 6 grams per day, taken orally in three to four times, and combined with blood concentration monitoring to evaluate the cumulative effect and tolerance of the drug in the body.

In the early stages of treatment, the dose should be adjusted gradually based on the patient's clinical response, plasma drug concentration and adverse reactions. The dose can usually be increased to 9 to 10 grams per day within weeks to months, so that the plasma mitotane level reaches 14-20 mg/L or the maximum safe dose tolerated by the individual. It is worth noting that mitotane has obvious fat solubility, easily accumulates in body fat, and has a long half-life. Therefore, even if the drug is stopped, drug residues in the body may continue for several weeks, which also affects the judgment of the duration of treatment. Clinically, the use period of mitotane often lasts for several months or even more than a year, especially in postoperative adjuvant therapy or late-stage tumor control. The treatment course may continue until the disease control is stable or obvious intolerance occurs.

During long-term use, patients need to regularly monitor adrenal gland function, liver function, blood lipids and nervous system to prevent drug accumulation and cause adverse reactions. Overseas guidelines emphasize that the treatment course of mitotane should not be mechanically fixed, but should be dynamically adjusted based on blood drug levels, efficacy evaluation and side effect management. Therefore, patients and doctors need to communicate closely to ensure that effective concentrations can be maintained while avoiding accumulation of toxicity.

In short, the duration of taking mitotane is highly dependent on individual tolerance, blood drug monitoring results and clinical efficacy. It can range from a few weeks for induction dose adjustment to a range of several months to more than a year. It is an indispensable long-term maintenance drug in the treatment of adrenocortical cancer.

Reference materials:https://go.drugbank.com/drugs/DB00648